{
    "Trade/Device Name(s)": [
        "AutoDELFIA Neonatal 17\u03b1-OH-progesterone kit"
    ],
    "Submitter Information": "Wallac Oy",
    "510(k) Number": "K081922",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042425"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JLX"
    ],
    "Summary Letter Date": "March 27, 2009",
    "Summary Letter Received Date": "April 2, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1395"
    ],
    "Regulation Name(s)": [
        "Radioimmunoassay, 17-Hydroxyprogesterone"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "17\u03b1-OH-progesterone"
    ],
    "Specimen Type(s)": [
        "Blood specimens dried on filter paper"
    ],
    "Specimen Container(s)": [
        "Filter paper disks (approx. 3.2 mm)",
        "Filter paper cassettes (Whatman Grade 903)"
    ],
    "Instrument(s)/Platform(s)": [
        "1235 AutoDELFIA automatic immunoassay system"
    ],
    "Method(s)/Technology(ies)": [
        "Time-resolved fluoroimmunoassay",
        "Competitive immunoassay",
        "Radioimmunoassay"
    ],
    "Methodologies": [
        "Immunoassay",
        "Time-resolved fluorescence detection"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for AutoDELFIA Neonatal 17\u03b1-OH-progesterone kit for quantitative measurement of 17\u03b1-OH-progesterone to aid screening for congenital adrenal hyperplasia in newborns",
    "Indications for Use Summary": "Intended for quantitative determination of human 17\u03b1-OH-progesterone in blood specimens dried on filter paper as an aid in screening newborns for congenital adrenal hyperplasia using the 1235 AutoDELFIA automatic immunoassay system",
    "fda_folder": "Clinical Chemistry"
}